The importance of LRP5 in bone was initially established by demonstrating that inactivating mutations in this co-receptor caused osteoporosis pseudoglioma (OPPG), a rare syndrome associated with premature and generalized osteoporosis [13]. The gene discussed is LRP5; the disease is osteoporosis-pseudoglioma syndrome.